Treatment of vaginal atrophy in women with tumor pathology risk

Details Treatment of vaginal atrophy in women with tumor pathology risk Treatment of vaginal atrophy in women with tumor pathology risk

A - Human Necessities

61

K

A61K 31/566 (2006.01) A61K 9/52 (2006.01) A61P 15/02 (2006.01)

Patent

CA 2732877

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal ad-ministration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen- dependent tumor or suffering or having suffered from an estrogen-dependent tumor.

La présente invention concerne l'utilisation d'striol dans la préparation d'une formulation pharmaceutique pour une administration vaginale, avec la capacité de limitation automatique de l'absorption d'striol, pour la prévention et/ou le traitement d'une atrophie urogénitale chez les femmes, lesdites femmes ayant une probabilité élevée de développer une tumeur dépendante de l'strogène ou de souffrir ou d'avoir souffert d'une tumeur dépendante de l'strogène.

Affiliated with

Also associated with

Rating

Treatment of vaginal atrophy in women with tumor pathology risk does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of vaginal atrophy in women with tumor pathology risk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of vaginal atrophy in women with tumor pathology risk will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1826229